Precept Management’s CryoPort CYRX Stock Holding History

Precept Management’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-17,500	Closed	-$1.1M	–	91
2021 Q2	$1.1M	Buy	+17,500	New	+$985K	0.46%	41
2020 Q4	–	Sell	-30,000	Closed	-$1.42M	–	65
2020 Q3	$1.42M	Buy	+30,000	New	+$1.22M	0.35%	48

Other funds holding CYRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Precept Management's CYRX Position: Q1 2022 in Review

Precept Management sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 15,000 shares — an estimated $888K sold.

Precept Management first reported a position in CYRX in Q1 2019 and held it in 12 quarters. The position peaked at $2.56M in Q2 2019. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.

Precept Management reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
Precept Management sold 15,000 CryoPort shares in Q1 2022, an estimated $888K.
Precept Management first reported a position in CryoPort in Q1 2019 and held it in 12 quarters.
Precept Management's CryoPort position peaked at $2.56M in Q2 2019.
200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.

Based on Precept Management's 13F filing for Q1 2022, filed 16 May 2022.